Last updated: April 10, 2026Bookmark

Overview

Contraception refers to methods or devices used to prevent pregnancy. It is also known as birth control or family planning. Before prescribing a contraceptive, pregnancy should be excluded.

Gillick competency (Fraser Guidelines) should be used to prescribe contraceptives in underage patients.

About 50% of pregnancies are unplanned. Without contraception, 80 – 90% of women become pregnant within a year of having regular sexual intercourse.

No contraception is 100% effective at preventing pregnancy

Culture and Contraception

CultureViews on contraception
HinduismThe use of contraception is encouraged. Hindu’s believe that they have a duty not to produce more children than their environment can support
SikhismThe decision to use contraception is left to individual couples
JudaismOrthodox Jews may prefer hormonal methods as they are perceived as more ‘natural’ than barrier methods. Calendar-based methods are discouraged as they typically coincide with ‘Niddah’ – the days when the woman is menstruating
IslamThe use of contraception is acceptable, although sterilisation may be discouraged. Throughout history, the ‘withdrawal method’ has been widely accepted in Islam
Protestants and AnglicansContraception is generally accepted
Roman catholicRecommends the use of natural family planning to anticipate when the woman is least fertile, i.e. fertility-awareness-based contraception

Fertility Awareness-Based Methods

Natural contraception

MethodExamples
RhytmTemperature method, cervical mucus method, calendar method, symptothermal method
Coitus interruptus
Lactational amenorrhoea

Temperature Method

Following ovulation, a woman’s basal body temperature rises by 0.2 – 0.4 C because of progesterone secretion from the corpus luteum.

Cervical mucus (Billing’s) Method

At the time of ovulation, under estrogen influence, the mucus becomes excessive, clear and stretchy. This is called fertile mucus (peak mucus).

Four days following peak mucus day, the mucus becomes thick, sticky and opaque because estrogen level has dropped

Barrier Methods

Barrier methods prevent the sperm from reaching the egg and provide additional protection from sexually transmitted infections.

Male condoms are 98% effective when used correctly. Female condoms are 95% effective when used correctly

  • Barrier methods
    • Male condom
    • Female condom
    • Diaphragm

Intrauterine contraception (IUDs)

IUDs are long-acting reversible contraceptives that are often recommended over other forms of shorter acting contraceptions. They are small T-shaped pieces of plastic coated with either copper or progesterone-releasing compound. They are inserted into the uterus transvaginally.

IUDs can be inserted 4 weeks after birth, and immediately after abortion.

IUDs have been quoted to be >99% effective. If taken correctly during the course of 5 years, <1% of women will become pregnant.

Intrauterine deviceDescription
Levonorgestrel-releasing intrauterine system (LNG-IUS, Mirena)May be left up to 5 years. Lower risk of PID, dysmenorrhoea, blood loss and ectopic pregnancy than copper IUD
Copper T380 A IUD (Paragard)May be left in for up to 10 years
  • Mechanism of action
    • Biochemical and histological changes in the endometrium
    • Impairs blastocysts’ implantation through enzymatic interference (copper IUD)
    • Prevents proliferation of the endometrium, making implantation difficult (hormonal IUD)
    • Thickens cervical mucus, creating a plug that the sperm cannot penetrate (hormonal IUD)
  • Benefits of IUD
    • Highly effective
    • Good for “poorly compliant” patients
    • Lasts several years
    • Periods eventually stop or lighten
  • Contraindications for IUD
    • Pregnant
    • Vaginal bleeding of unknown aetiology
    • Acute infection of the reproductive tract
    • Prior ectopic pregnancy
    • History of an STI in the past 3 months
    • Anatomic anomaly or fibroid uterus
    • Menorrhagia (ParaGard)
    • Current breast cancer (Mirena)
    • Copper allergy, Wilson’s disease (ParaGard)
  • Disadvantages of IUD
    • Insertion and removal require a trained provider
    • Perforation and Pelvic inflammatory disease can occur
    • Method failure can lead to an ectopic pregnancy
    • Can cause cramping and increased/prolonged bleeding
    • Expulsion and displacement of the IUD can occur with uterine contractions
    • Longer and heavier periods during the first few months

Progestin implants

Progestin implants are rod-shaped implants that slowly release progesterone and provide contraception for up to 3 – 5 years. They are commonly placed subcutaneously in the biceps groove and are covered in a polymer to prevent fibrosis.

Progestin implants can be fitted on or before day 21 of the menstrual cycle and provide immediate protection. If fitted after day 21, additional contraception will need to be used for 7 days. They can be fitted immediately after a miscarriage

Progestin implants are 99.5% effective at preventing pregnancy. 1 in 200 women will get pregnant in the course of a year when used as the sole form of contraception.

ImplantDescription
Levonorgestrel subdermal implant (Jadelle)2-rod progestin implant. Approved for 5 years
Etonorgestrel subdermal implant (Implanon, Nexplanon)Single-rod progestin implant. Approved for 5 years
  • Mechanism of action
    • Thickens cervical mucous
    • Prevents the proliferation of the endometrium, making implantation difficult
    • Inhibits ovulation
  • Contraindications to progestin implant
    • Pregnancy
    • Current or past history of thrombosis or thromboembolic disorders
    • Liver tumour (benign or malignant)
    • Active liver disease
    • History of breast cancer or current breast cancer
  • Benefits of progestin implant
    • Highly effective
    • Good for “poorly compliant” patients
    • Lasts for up to three years
    • Less risk of expulsion (compared to intrauterine devices)
    • Does not affect bone density (unlike injectable progesterone)
    • More likely to inhibit ovulation compared to POPs, hence reduced risk of ovarian cysts and ectopic pregnancy
  • Disadvantages of the progestin implant
    • Unexpected bleeding pattern (20% have amenorrhoea, 60% have irregular periods, 20% have frequent or prolonged bleeding). Mostly improves within 3 months
    • Spontaneous “Silent” expulsion
    • More cumbersome to implant/replace
  • Side effects of progestin implants
    • Acne
    • Breat tenderness
    • Mood swings
    • Changes in libido
    • Small risk of infection at the implant site
  • Drug interactions
    • CP450 inducers: recommended to use additional contraception for the duration of treatment and 4 weeks after

Combined Oral Contraceptive Pills (COCPs)

Combined oral contraceptives are frequently prescribed, even though they are the most complex method of contraception. They contain Estrogen and Progestin components, which are taken in cycles. Both monophasic and diphasic pills are in a 21-day supply with a 7-day break to allow breakthrough bleeding.

COCPs are started on day 1 of the cycle. If starting after day 4, another method of contraception should be used for 7 days. If changing from POPs, start on the first day of the cycle or exclude pregnancy (if amenorrhoea), then start on any day. It can be started 3 weeks after delivery and immediately after abortion.

COCPs are > 99% effective when taken correctly.

COCPsDescription
Monophasic pillsFixed dosage pills
Multiphasic pillsVariable dosage pills. Exposes the patient to fewer hormones, thereby reducing adverse effects
  • Mechanism of action
    • Prevents ovulation by impairing dominant follicular development
    • Thickens cervical mucus (progesterone component)
    • Endometrial hypoplasia (progesterone component)
  • Contraindications of COCPs
    • Pregnancy or nursing (reduces milk letdown and increases risk of VTEs)
    • History of Thromboembolism/pulmonary embolism
    • History of Coronary Artery Disease
    • History of CVA
    • Smoker > 35 years of age
    • History of breast or endometrial cancer
    • Unexplained vaginal bleeding
    • Abnormal liver function
    • Severe cholesterol or triglyceride elevations
    • Migraines
    • Seizure disorder (can interfere with seizure medications)
    • High risk for vascular disease and over the age of 40 **
    • Hypertension
    • Diabetes
  • Complications of COCs
  • Benefits of COCPs
    • Highly effective when taken appropriately (> 99% effective)
    • Reduces the risk of endometrial and ovarian cancer
    • Reduces risk of osteoporosis
    • Treats a variety of disorders
  • Disadvantages of COCs
    • Must take the pill daily
    • Preparations may be confusing
    • Long list of contraindications
    • Long list of drug interactions
    • Increased risk of cervical dysplasia and cancer
    • Increased risk of gallbladder disease
    • Increased risk of benign hepatic tumours (especially adenoma)
  • Side effects of COCs
    • Nausea
    • Headache
    • Breakthrough bleeding
    • Weight gain

Progestin-only pills (POPs)

Progestin-only pills are normally taken when COCs are contraindicated. They contain small doses of progesterone taken daily without estrogen, i.e., they are taken every day of the cycle with no placebo phase. Missing a pill results in fertility for about 48 hours.

POPs can be started on the first day of the cycle with immediate protection. If started after 5 days, the barrier method can be used for 2 days.

POPs can be started immediately after abortion and pregnancy.

  • Mechanism of action
    • Thickens cervical mucus
    • Alters the endometrium, making it difficult for implantation to occur
    • High doses of POPs can inhibit ovulation
  • Contraindications of POPs
    • Previous cysts or ectopic (have a slightly increased risk of ectopic pregnancy)
  • Side effects of POPs
    • Irregular ovulatory cycles
    • Breakthrough bleeding
    • Increased formation of follicular cysts
    • Acne
    • Breast tenderness
    • Risk of ectopic pregnancy
  • Benefits of POPs
    • May be taken by women when oestrogen-containing contraceptives are contraindicated
    • Can be used when breastfeeding
  • Disadvantages of POPs
    • Less effective (failure rate of 8%)
    • Must take at the same time every day
    • Irregular menses

Injectable progestins

Injectable progestins are typically given every 3 months. The most problematic side effect is bone demineralisation. They can also cause an erratic return to normal menstruation after being stopped.

Injectable progestins can be administered within 5 days of the start of the cycle. If it started on any other day, another method of contraception should be used for the first 7 days. It is usually started 6 weeks after pregnancy and immediately after abortion.

Injectable progestins are 99% effective at preventing pregnancy.

Injectable progestinDescription
Depot-Medroxyprogesterone Acetate (DMPA, Depo-Provera)The most common preparation of injectable progestin. Administered every 90 days (3 months) via intramuscular route. Adverse effects and contraindications are similar to progestin-only pills
Norethisterone enantate (Noristerat)Administered every 60 days (2 months) via the intramuscular route. Less effective than DMPA. A short-term option for women waiting for sterilisation
  • Mechanism of action
    • Prevents endometrial proliferation
    • Thickens cervical mucus
    • Prevents ovulation
  • What is the most problematic side effect of injectable progestins?
    • Bone demineralisation
    • The maximum effect is at 1 year, then increases gradually with more years of use.
    • Women should be advised to take Vitamin D and do weight-bearing exercises
  • Benefits of injectable progestins
    • Highly effective (>99%)
    • Injections are only needed every 3 months
    • Reduces the risk of endometrial and ovarian cancers
    • Useful in the treatment of menorrhagia, dysmenorrhea, and endometriosis
    • May be used in patients where oestrogen-containing contraceptives are contraindicated
    • Can be used in breastfeeding patients and epileptics
  • Disadvantages of injectable progestins
    • Bone demineralisation: hence should not be first-line in women < 18 or > 45 years old. Avoid in patients with risk factors for osteoporosis
    • Increased risk of cervical carcinoma in situ
    • Delay in return of regular ovulation when discontinued (median of 10 months)
  • Side effects of injectable progestins
  • Contraindications of injectable progestins
    • Undiagnosed abnormal bleeding
    • Severe cardiac disease
    • Acute liver disease

Patches

Patches are analogous to COCs and have a similar adverse effect and contraindication profile. Their usage has declined over the years due to litigation, but there is no evidence supporting increased morbidity with patch vs. other combined hormonal contraceptive methods.

PatchDescription
Norelgestromin/Ethinyl estradiol transdermal (Ortho Evra Patch):Applied for three weeks, then removed

Vaginal ring

Etonorgestrel/ethinylestradiol (NuvaRing)

Emergency Contraception

Emergency contraception is a post-coital method of contraception. They prevent ovulation, fertilisation and/or implantation from occurring. These methods do not cause any alteration to an embryo after implantation.

Emergency contraceptiveDescriptionPregnancy rate if taken within 120 hours
Levonorgestrel (LNG)Progesterone-only emergency contraception (POEC). This is the traditional ‘morning after pill’. It should be taken within 72 hours of coitus2.2%
Ulipristal acetate (UPA)Selective progesterone receptor modulator (SPRM). It is more effective than levonorgestrel and can be taken up to 120 hours (5 days) after coitus.1.4%
Copper IUDThis is the most effective method of emergency contraception, even for women presenting after 72 hours<1%

Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Leave a Reply

Your email address will not be published. Required fields are marked *

A moment of your time
Step 1 of 2

You are the reason this exists. Got 60 seconds? Help us improve Hyperexcision for every medical student who uses it.

The Hyperexcision Team